findmyKOL
Clinical trialNCT01837810UnknownInterventional

Safety Study of Post Tonsillectomy Ibuprofen Use in Adults

SponsorBrooke Army Medical CenterEnrollment810Primary Post Tonsillectomy HemorrhageSecondary Post Tonsillectomy Hemorrhage
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to determine if ibuprofen use after electrocautery tonsillectomy increases the post-tonsillectomy hemorrhage rate. Hypothesis: Use of ibuprofen does not increase the post-tonsillectomy hemorrhage rate. Primary outcome: Rate of tonsillar hemorrhage following adult tonsillectomy in those receiving narcotic pain medications plus ibuprofen compared to those receiving narcotics alone. Secondary outcome: Determine whether ibuprofen, a non-steroidal anti-inflammatory drug (NSAID), decreases post tonsillectomy pain, narcotic pain medication use, or cost of pain management.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Brooke Army Medical Center

    Fort Sam Houston, Texas, United States

    Gregory R Dion, MD, MS
    Recruiting
  • Wilford Hall Ambulatory Surgical Center

    Lackland Air Force Base, Texas, United States

    Thomas J Willson, MD
    Not, yet, recruiting
  • Madigan Army Medical Center

    Tacoma, Washington, United States

    Del R Sloneker, MD
    Not, yet, recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Apr 2013
Primary completion
30 Apr 2016
Completion
31 May 2016
Last update posted
24 Apr 2013
Registered enrollment
810
Registry id
NCT01837810

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.